LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 39

Search options

  1. Article ; Online: Commentary: The severity of chronic obstructive pulmonary disease affects outcomes of thoracoabdominal aortic aneurysms repair-is GOLD the answer?

    Lopez-Marco, Ana / Oo, Aung Y

    The Journal of thoracic and cardiovascular surgery

    2023  

    Language English
    Publishing date 2023-10-21
    Publishing country United States
    Document type Editorial
    ZDB-ID 3104-5
    ISSN 1097-685X ; 0022-5223
    ISSN (online) 1097-685X
    ISSN 0022-5223
    DOI 10.1016/j.jtcvs.2023.10.039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Intercostal artery reattachment for prevention of spinal cord ischaemia.

    Lopez-Marco, Ana / Thet, Myat Soe / Sajiram, Sarvananthan / Adams, Benjamin / Oo, Aung Y

    Annals of cardiothoracic surgery

    2023  Volume 12, Issue 5, Page(s) 511–513

    Language English
    Publishing date 2023-09-20
    Publishing country China
    Document type Editorial
    ZDB-ID 2713627-9
    ISSN 2304-1021 ; 2225-319X
    ISSN (online) 2304-1021
    ISSN 2225-319X
    DOI 10.21037/acs-2023-scp-09
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Efficacy of chest X-rays after drain removal in adult and pediatric patients undergoing cardiac and thoracic surgery: A systematic review.

    Thet, Myat S / Han, Khin P P / Hlwar, Khun E / Thet, Khaing S / Oo, Aung Y

    Journal of cardiac surgery

    2022  Volume 37, Issue 12, Page(s) 5320–5325

    Abstract: Background: Chest X-rays are routinely obtained after the removal of chest drains in patients undergoing cardiac and thoracic surgical procedures. However, a lack of guidelines and evidence could question the practice. Routine chest X-rays increase ... ...

    Abstract Background: Chest X-rays are routinely obtained after the removal of chest drains in patients undergoing cardiac and thoracic surgical procedures. However, a lack of guidelines and evidence could question the practice. Routine chest X-rays increase exposure to ionizing radiation, increase health-care costs, and lead to overutilisation of available resources. This review aims to explore the evidence in the literature regarding the routine use of chest X-rays following the removal of chest drains.
    Materials & method: A systematic literature search was conducted in PubMed, Medline via Ovid, Cochrane central register of control trials (CENTRAL), and ClinicalTrials. gov without any limit on the publication year. The references of the included studies are manually screened to identify potentially eligible studies.
    Results: A total of 375 studies were retrieved through the search and 18 studies were included in the review. Incidence of pneumothorax remains less than 10% across adult cardiac, and pediatric cardiac and thoracic surgical populations. The incidence may be as high as 50% in adult thoracic surgical patients. However, the reintervention rate remains less than 2% across the populations. Development of respiratory and cardiovascular symptoms can adequately guide for a chest X-ray following the drain removal. As an alternative, bedside ultrasound can be used to detect pneumothorax in the thorax after the removal of a chest drain without the need for ionizing radiation.
    Conclusion: A routine chest X-ray following chest drain removal in adult and pediatric patients undergoing cardiac and thoracic surgery is not necessary. It can be omitted without compromising patient safety. Obtaining a chest X-ray should be clinically guided. Alternatively, bedside ultrasound can be used for the same purpose without the need for radiation exposure.
    MeSH term(s) Humans ; Adult ; Child ; X-Rays ; Pneumothorax ; Thoracic Surgery ; Thoracic Surgical Procedures/methods ; Heart ; Radiography, Thoracic
    Language English
    Publishing date 2022-11-06
    Publishing country United States
    Document type Systematic Review ; Journal Article ; Review
    ZDB-ID 639059-6
    ISSN 1540-8191 ; 0886-0440
    ISSN (online) 1540-8191
    ISSN 0886-0440
    DOI 10.1111/jocs.17114
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: On-X aortic valve replacement patients treated with low dose warfarin and low dose aspirin.

    Oo, Aung Y / Loubani, Mahmoud / Gerdisch, Marc W / Zacharias, Joseph / Tsang, Geoffrey M / Perchinsky, Michael J / Hagberg, Robert Carl / Joseph, Mark / Sathyamoorthy, Mohanakrishnan

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

    2024  

    Abstract: Objectives: To assess if warfarin targeted to INR 1.8 (range 1.5-2.0) is safe for all patients with an On-X aortic mechanical valve.: Methods: This prospective, observational registry follows patients receiving warfarin targeted at an INR of 1.8 ( ... ...

    Abstract Objectives: To assess if warfarin targeted to INR 1.8 (range 1.5-2.0) is safe for all patients with an On-X aortic mechanical valve.
    Methods: This prospective, observational registry follows patients receiving warfarin targeted at an INR of 1.8 (range 1.5-2.0) plus daily aspirin (75-100 mg) after On-X aortic valve replacement. The primary end-point is a composite of thromboembolism, valve thrombosis, and major bleeding. Secondary end-points include the individual rates of thromboembolism, valve thrombosis, and major bleeding, as well as the composite in subgroups of home or clinic-monitored INR and risk categorization for thromboembolism. The control was the patient group randomized to standard-dose warfarin (INR 2.0-3.0) plus daily aspirin 81 mg from the PROACT trial.
    Results: A total of 510 patients were enrolled at 23 centers in the UK, United States, and Canada. Currently, the median follow-up duration is 3.4 years, and median achieved INR is 1.9. The primary composite end-point rate in the low INR patients is 2.31% vs 5.39% (95% confidence interval 4.12%-6.93%) per patient-year in the PROACT control group, constituting a 57% reduction. Results are consistent in subgroups of home or clinic-monitored, and high-risk patients, with reductions of 56%, 57%, and 57%, respectively. Major and total bleeding are decreased by 85% and 73%, respectively, with similar rates of thromboembolic events. No valve thrombosis occurred.
    Conclusions: Interim results suggest that warfarin targeted at an INR of 1.8 (range 1.5-2.0) plus aspirin is safe and effective in patients with an On-X aortic mechanical valve with or without home INR monitoring.
    Language English
    Publishing date 2024-04-15
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 639293-3
    ISSN 1873-734X ; 1010-7940 ; 1567-4258
    ISSN (online) 1873-734X
    ISSN 1010-7940 ; 1567-4258
    DOI 10.1093/ejcts/ezae117
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: An unusual cause of heart failure in a young female: a case of massive left atrial mxyoma.

    Shafi, Ahmed Mohamed Abdel / Akhtar, Mohammed A / Smith, Alexander / Yates, Martin / Oo, Aung Y

    Journal of cardiac surgery

    2020  Volume 35, Issue 11, Page(s) 3227–3230

    Abstract: Benign cardiac tumors are rare; they can present with nonspecific symptoms and represent a diagnostic challenge to the clinician. We describe an interesting case of a 26-year-old female who presented with a 6-month history of cough, breathlessness, ... ...

    Abstract Benign cardiac tumors are rare; they can present with nonspecific symptoms and represent a diagnostic challenge to the clinician. We describe an interesting case of a 26-year-old female who presented with a 6-month history of cough, breathlessness, palpitations, dizziness, and fever. Despite repeated clinical reviews in the community, diagnosis of cardiac tumor was not made until she developed decompensated cardiac failure with bilateral pleural effusions and pulmonary edema. Echocardiogram revealed an enormous left atrial mass that extended one-third into left ventricle during systole. The patient underwent successful surgical resection with histological confirmation of a benign atrial myxoma.
    MeSH term(s) Adult ; Cardiac Surgical Procedures/methods ; Echocardiography ; Female ; Heart Atria ; Heart Failure/etiology ; Heart Failure/surgery ; Heart Neoplasms/complications ; Heart Neoplasms/diagnostic imaging ; Heart Neoplasms/pathology ; Heart Neoplasms/surgery ; Humans ; Myxoma/complications ; Myxoma/diagnostic imaging ; Myxoma/pathology ; Myxoma/surgery ; Systole ; Treatment Outcome
    Language English
    Publishing date 2020-08-25
    Publishing country United States
    Document type Case Reports
    ZDB-ID 639059-6
    ISSN 1540-8191 ; 0886-0440
    ISSN (online) 1540-8191
    ISSN 0886-0440
    DOI 10.1111/jocs.14978
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery.

    Yates, Martin T / Balmforth, Damian / Lopez-Marco, Ana / Uppal, Rakesh / Oo, Aung Y

    Interactive cardiovascular and thoracic surgery

    2020  Volume 31, Issue 4, Page(s) 483–485

    Abstract: The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to assess ... ...

    Abstract The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to assess the outcomes of patients undergoing cardiac surgery who have COVID-19 infection diagnosed in the early postoperative period. We identified 9 patients who developed COVID-19 infection following cardiac surgery. These patients had a significant length of hospital stay and extremely poor outcomes with mortality of 44%. In conclusion, the outcome of cardiac surgical patients who contracted COVID-19 infection perioperatively is extremely poor. In order to offer cardiac surgery, units must implement rigorous protocols aimed at maintaining a COVID-19 protective environment to minimize additional life-threatening complications related to this virus infection.
    MeSH term(s) Adult ; Aged ; Betacoronavirus ; COVID-19 ; Cardiac Surgical Procedures/methods ; Comorbidity ; Coronavirus Infections/epidemiology ; Elective Surgical Procedures/methods ; Female ; Heart Diseases/epidemiology ; Heart Diseases/surgery ; Humans ; Length of Stay ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; Postoperative Period ; SARS-CoV-2 ; Time Factors ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-08-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivaa143
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Matrix Metalloproteinase in Abdominal Aortic Aneurysm and Aortic Dissection.

    Maguire, Eithne M / Pearce, Stuart W A / Xiao, Rui / Oo, Aung Y / Xiao, Qingzhong

    Pharmaceuticals (Basel, Switzerland)

    2019  Volume 12, Issue 3

    Abstract: Abdominal Aortic Aneurysm (AAA) affects 4-5% of men over 65, and Aortic Dissection (AD) is a life-threatening aortic pathology associated with high morbidity and mortality. Initiators of AAA and AD include smoking and arterial hypertension, whilst key ... ...

    Abstract Abdominal Aortic Aneurysm (AAA) affects 4-5% of men over 65, and Aortic Dissection (AD) is a life-threatening aortic pathology associated with high morbidity and mortality. Initiators of AAA and AD include smoking and arterial hypertension, whilst key pathophysiological features of AAA and AD include chronic inflammation, hypoxia, and large modifications to the extra cellular matrix (ECM). As it stands, only surgical methods are available for preventing aortic rupture in patients, which often presents difficulties for recovery. No pharmacological treatment is available, as such researchers are attempting to understand the cellular and molecular pathophysiology of AAA and AD. Upregulation of matrix metalloproteinase (MMPs), particularly MMP-2 and MMP-9, has been identified as a key event occurring during aneurysmal growth. As such, several animal models of AAA and AD have been used to investigate the therapeutic potential of suppressing MMP-2 and MMP-9 activity as well as modulating the activity of other MMPs, and TIMPs involved in the pathology. Whilst several studies have offered promising results, targeted delivery of MMP inhibition still needs to be developed in order to avoid surgery in high risk patients.
    Language English
    Publishing date 2019-08-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph12030118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery

    Yates, Martin T / Balmforth, Damian / Lopez-Marco, Ana / Uppal, Rakesh / Oo, Aung Y

    Interact Cardiovasc Thorac Surg

    Abstract: The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to assess ... ...

    Abstract The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to assess the outcomes of patients undergoing cardiac surgery who have COVID-19 infection diagnosed in the early postoperative period. We identified 9 patients who developed COVID-19 infection following cardiac surgery. These patients had a significant length of hospital stay and extremely poor outcomes with mortality of 44%. In conclusion, the outcome of cardiac surgical patients who contracted COVID-19 infection perioperatively is extremely poor. In order to offer cardiac surgery, units must implement rigorous protocols aimed at maintaining a COVID-19 protective environment to minimize additional life-threatening complications related to this virus infection.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #714481
    Database COVID19

    Kategorien

  9. Article ; Online: Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery

    Yates, Martin T / Balmforth, Damian / Lopez-Marco, Ana / Uppal, Rakesh / Oo, Aung Y

    Interactive CardioVascular and Thoracic Surgery

    2020  Volume 31, Issue 4, Page(s) 483–485

    Abstract: Abstract The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to ...

    Abstract Abstract The coronavirus 2019 (COVID-19) pandemic has disrupted patient care across the NHS. Following the suspension of elective surgery, priority was placed in providing urgent and emergency surgery for patients with no alternative treatment. We aim to assess the outcomes of patients undergoing cardiac surgery who have COVID-19 infection diagnosed in the early postoperative period. We identified 9 patients who developed COVID-19 infection following cardiac surgery. These patients had a significant length of hospital stay and extremely poor outcomes with mortality of 44%. In conclusion, the outcome of cardiac surgical patients who contracted COVID-19 infection perioperatively is extremely poor. In order to offer cardiac surgery, units must implement rigorous protocols aimed at maintaining a COVID-19 protective environment to minimize additional life-threatening complications related to this virus infection.
    Keywords Surgery ; Pulmonary and Respiratory Medicine ; Cardiology and Cardiovascular Medicine ; covid19
    Language English
    Publisher Oxford University Press (OUP)
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 2095298-3
    ISSN 1569-9285 ; 1569-9293
    ISSN (online) 1569-9285
    ISSN 1569-9293
    DOI 10.1093/icvts/ivaa143
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Effect of Hospital-associated SARS-CoV-2 Infections in Cardiac Surgery: A Multicenter Study.

    Spadaccio, Cristiano / Rose, David / Candura, Dario / Lopez Marco, Ana / Cerillo, Alfredo / Stefano, Pierluigi / Nasso, Giuseppe / Ramoni, Enrico / Fattouch, Khalil / Minacapelli, Alberto / Oo, Aung Y / Speziale, Giuseppe / Shelton, Kenneth / Berra, Lorenzo / Bose, Amal / Moscarelli, Marco

    The Annals of thoracic surgery

    2022  Volume 117, Issue 1, Page(s) 213–219

    Abstract: Background: The effect of hospital-associated SARS-CoV-2 infections in cardiac surgery patients remains poorly investigated, and current data are limited to small case series with conflicting results.: Methods: A multicenter European collaboration ... ...

    Abstract Background: The effect of hospital-associated SARS-CoV-2 infections in cardiac surgery patients remains poorly investigated, and current data are limited to small case series with conflicting results.
    Methods: A multicenter European collaboration was organized to analyze the outcomes of patients who tested positive with hospital-associated SARS-CoV-2 infection after cardiac surgery. The study investigators hypothesized that early infection could be associated with worse postoperative outcomes; hence 2 groups were considered: (1) an early hospital-associated SARS-CoV-2 infection group comprising patients who had a positive molecular test result ≤7 days after surgery, with or without symptoms; and (2) a late hospital-associated SARS-CoV-2 infection group comprising patients whose test positivity occurred >7 days after surgery, with or without symptoms. The primary outcome was 30-day mortality. Secondary outcomes included all-cause mortality or morbidity at early follow-up and SARS-CoV-2-related hospital readmission.
    Results: A total of 87 patients were included in the study. Of those, 30 were in the early group and 57 in the late group. Overall, 30-day mortality was 8%, and in-hospital mortality was 11.5%. The reintubation rate was 11.4%. Early infection was significantly associated with higher mortality (adjusted OR, 26.6; 95% CI, 2, 352.6; P < .01) when compared with the late group. At 6-month follow-up, survival probability was also significantly higher in the late infection group: 91% (95% CI, 83%, 98%) vs 75% (95% CI, 61%, 93%) in the early infection group (P = .036). Two patients experienced COVID-19-related rehospitalization.
    Conclusions: In this multicenter analysis, hospital-associated SARS-CoV-2 infection resulted in higher than expected postoperative mortality after cardiac surgery, especially in the early infection group.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Hospitals ; Cardiac Surgical Procedures/adverse effects ; Hospital Mortality
    Language English
    Publishing date 2022-06-08
    Publishing country Netherlands
    Document type Multicenter Study ; Journal Article
    ZDB-ID 211007-6
    ISSN 1552-6259 ; 0003-4975
    ISSN (online) 1552-6259
    ISSN 0003-4975
    DOI 10.1016/j.athoracsur.2022.05.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top